Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.
Alksne LE, Burgio P, Hu W, Feld B, Singh MP, Tuckman M, Petersen PJ, Labthavikul P, McGlynn M, Barbieri L, McDonald L, Bradford P, Dushin RG, Rothstein D, Projan SJ. Alksne LE, et al. Antimicrob Agents Chemother. 2000 Jun;44(6):1418-27. doi: 10.1128/AAC.44.6.1418-1427.2000. Antimicrob Agents Chemother. 2000. PMID: 10817687 Free PMC article.
In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.
Weiss WJ, Petersen PJ, Murphy TM, Tardio L, Yang Y, Bradford PA, Venkatesan AM, Abe T, Isoda T, Mihira A, Ushirogochi H, Takasake T, Projan S, O'Connell J, Mansour TS. Weiss WJ, et al. Among authors: bradford pa. Antimicrob Agents Chemother. 2004 Dec;48(12):4589-96. doi: 10.1128/AAC.48.12.4589-4596.2004. Antimicrob Agents Chemother. 2004. PMID: 15561830 Free PMC article.
Late stage antibacterial drugs in the clinical pipeline.
Projan SJ, Bradford PA. Projan SJ, et al. Among authors: bradford pa. Curr Opin Microbiol. 2007 Oct;10(5):441-6. doi: 10.1016/j.mib.2007.08.007. Epub 2007 Oct 22. Curr Opin Microbiol. 2007. PMID: 17950658 Review.
Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Mendes RE, et al. Among authors: bradford pa. Int J Antimicrob Agents. 2018 Aug;52(2):287-292. doi: 10.1016/j.ijantimicag.2018.04.001. Epub 2018 Apr 11. Int J Antimicrob Agents. 2018. PMID: 29654893 Clinical Trial.
123 results